PDA today announced the winners of the 2025 PDA Drug Delivery Innovation Awards at the 2025 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Vienna, Austria.
BETHESDA, Md., Oct. 21, 2025 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the winners of the 2025 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2025 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Vienna, Austria.
Flex and Merck won the PDA Drug Delivery Innovation Award for Empowering Patients: The Benefits of Connected Injection Devices on Health Outcomes – A Focus on Autoinjectors. AstraZeneca and Team Consulting won the PDA Drug Delivery Partnership Innovation Award for Pioneering Digital Instructions for the Fasenra Autoinjector.
This highly sought award recognizes outstanding achievements in technical innovation. Recipients are celebrated for their significant contributions, which not only advance manufacturing practices but also improve patient outcomes. Earning this award distinguishes individuals and organizations as leaders in their field, reflecting their commitment to pushing the boundaries of drug delivery science and technology.
"Since its inception in 2019, the PDA Drug Delivery Innovation Awards have honored groundbreaking advancements that shape the future of bio/pharmaceutical manufacturing," said Glenn E. Wright, President and CEO of PDA. "The Innovation Award celebrates novel devices, processes, methods, or automation that deliver meaningful value to the industry. The Partnership Innovation Award highlights the power of collaboration in successfully launching new products or significantly enhancing existing ones to improve scalability and impact."
Matthew Keiser, Merck and Marco Rigamonti, Flex developed the next generation electromechanical autoinjector, enabling a smooth and convenient patient treatment experience and empowers health care providers with real-time data. With a smartphone-like large color touch screen, personalized settings, and on-screen, step-by-step guidance, it is easy for patients to use.
Katie Cornish, AstraZeneca and Thomas Grant, Team Consulting developed an interactive digital instruction to support patient onboarding and adherence for the Fasenra autoinjector. The partners saw an opportunity to address this unmet user need and develop an interactive digital set of instructions to supplement the paper instructions for the Fasenra Pen.
About PDA
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. PDA creates awareness and understanding of important issues facing the pharma community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharma manufacturing science and regulation, so members can better serve patients.
Media Contact
Walter Morris, www.pda.org, 1 3016565900, [email protected], www.pda.org
SOURCE www.pda.org
Share this article